Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNE.L Regulatory News (HNE)

  • There is currently no data for HNE

Performance is getting back on track

27 Jul 2023 07:15

RNS Number : 3034H
Henderson Eurotrust PLC
27 July 2023
 

London, UK, 27 July 2023

 

Henderson EuroTrust (HNE): Performance is getting back on track.

Henderson EuroTrust's (HNE's) performance is getting back on track as investors have become more focused on company fundamentals rather than macroeconomic factors, and investors' strong preference for value stocks (translating into style headwinds for HNE between Q121 and Q222) has waned recently. The manager (Jamie Ross) is building on HNE's NAV 10-year record of outperformance versus the Europe ex-UK market (10.5% pa versus 9.1% pa respectively), based on a concentrated portfolio of high-quality growth stocks. European equities are very attractively valued and, coupled with the trust's double-digit discount, this should make HNE worthy of consideration.

 

There is scope for the trust to be afforded a higher valuation now its performance is improving, or if investors become less risk-averse. HNE has one of the widest discounts in its sector despite its performance being above average over the last one, five and 10 years.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAXQLFLXDLZBBQ
Date   Source Headline
9th Feb 202312:37 pmRNSNet Asset Value(s)
8th Feb 202312:39 pmRNSNet Asset Value(s)
7th Feb 202312:24 pmRNSNet Asset Value(s)
6th Feb 20232:30 pmRNSNet Asset Value(s)
3rd Feb 202311:39 amRNSNet Asset Value(s)
2nd Feb 202312:36 pmRNSNet Asset Value(s)
1st Feb 20232:28 pmRNSNet Asset Value(s)
1st Feb 20239:39 amRNSBlock listing Interim Review
31st Jan 20231:23 pmRNSNet Asset Value(s)
30th Jan 20231:57 pmRNSNet Asset Value(s)
27th Jan 20231:52 pmRNSNet Asset Value(s)
26th Jan 202312:09 pmRNSNet Asset Value(s)
25th Jan 202310:54 amRNSNet Asset Value(s)
24th Jan 202311:59 amRNSNet Asset Value(s)
23rd Jan 20232:20 pmRNSNet Asset Value(s)
23rd Jan 202311:32 amRNSMonthly Factsheet as at 31 December 2022
20th Jan 202312:24 pmRNSNet Asset Value(s)
19th Jan 202312:07 pmRNSNet Asset Value(s)
18th Jan 20234:37 pmRNSNet Asset Value(s)
16th Jan 20231:55 pmRNSNet Asset Value(s)
13th Jan 202312:54 pmRNSNet Asset Value(s)
12th Jan 202312:23 pmRNSNet Asset Value(s)
11th Jan 202312:00 pmRNSNet Asset Value(s)
10th Jan 202311:31 amRNSNet Asset Value(s)
9th Jan 20234:25 pmRNSNet Asset Value(s)
6th Jan 202312:54 pmRNSNet Asset Value(s)
5th Jan 202312:15 pmRNSNet Asset Value(s)
4th Jan 202312:08 pmRNSNet Asset Value(s)
3rd Jan 20233:51 pmRNSNet Asset Value(s)
30th Dec 202212:54 pmRNSNet Asset Value(s)
29th Dec 202212:53 pmRNSNet Asset Value(s)
28th Dec 202212:55 pmRNSNet Asset Value(s)
28th Dec 20227:00 amRNSHolding(s) in Company
28th Dec 20227:00 amRNSHolding(s) in Company
23rd Dec 202211:16 amRNSNet Asset Value(s)
22nd Dec 20223:24 pmRNSMonthly Factsheet as at 30 November 2022
22nd Dec 202211:51 amRNSNet Asset Value(s)
21st Dec 202212:32 pmRNSNet Asset Value(s)
20th Dec 202211:22 amRNSNet Asset Value(s)
19th Dec 20223:05 pmRNSNet Asset Value(s)
16th Dec 202211:16 amRNSNet Asset Value(s)
15th Dec 202212:10 pmRNSNet Asset Value(s)
14th Dec 202212:01 pmRNSNet Asset Value(s)
13th Dec 202212:01 pmRNSNet Asset Value(s)
12th Dec 20223:13 pmRNSNet Asset Value(s)
9th Dec 202212:26 pmRNSNet Asset Value(s)
8th Dec 20221:26 pmRNSNet Asset Value(s)
7th Dec 20221:18 pmRNSNet Asset Value(s)
6th Dec 202212:11 pmRNSNet Asset Value(s)
5th Dec 20222:08 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.